Drug use and opioid substitution treatment for prisoners

被引:51
|
作者
Stoever, Heino [1 ]
Michels, Ingo Ilja [2 ]
机构
[1] Univ Appl Sci, Res Inst Addict, D-60318 Frankfurt, Germany
[2] Deutsch Gesell Tech Zusammenarbeit GTZ, Cent Asia Drug Act Programme CADAP European Union, Bishkek, Kyrgyzstan
关键词
METHADONE-MAINTENANCE TREATMENT; RANDOMIZED CONTROLLED-TRIAL; HEPATITIS-C; BUPRENORPHINE; TRANSMISSION; RISK; HIV; ATTITUDES; INJECTION;
D O I
10.1186/1477-7517-7-17
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Drug use is prevalent throughout prison populations, and, despite advances in drug treatment programmes for inmates, access to and the quality of these programmes remain substantially poorer than those available for non-incarcerated drug users. Because prisoners may be at greater risk for some of the harms associated with drug use, they deserve therapeutic modalities and attitudes that are at least equal to those available for drug users outside prison. This article discusses drug use by inmates and its associated harms. In addition, this article provides a survey of studies conducted in prisons of opioid substitution therapy (OST), a clinically effective and cost-effective drug treatment strategy. The findings from this overview indicate why treatment efforts for drug users in prison are often poorer than those available for drug users in the non-prison community and demonstrate how the implementation of OST programmes benefits not only prisoners but also prison staff and the community at large. Finally, the article outlines strategies that have been found effective for implementing OST in prisons and offers suggestions for applying these strategies more broadly.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] High-risk drug-use practices among a large sample of Australian prisoners
    Kinner, Stuart A.
    Jenkinson, Rebecca
    Gouillou, Maelenn
    Milloy, M-J
    DRUG AND ALCOHOL DEPENDENCE, 2012, 126 (1-2) : 156 - 160
  • [32] Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances
    Castillo, Felipe
    Hu, Mei-Chen
    Liu, Ying
    Balise, Raymond R.
    Weiss, Roger D.
    Rotrosen, John
    Nunes, Edward, V
    Saxon, Andrew J.
    Feaster, Daniel J.
    Luo, Sean X.
    DRUG AND ALCOHOL DEPENDENCE, 2023, 251
  • [33] Drug Dependent Prisoners - Epidemiology, Prevention and Treatment in Total Institutions
    Stoever, H.
    SUCHTTHERAPIE, 2012, 13 (02) : 74 - 80
  • [34] Predictors of Illicit Drug Use Among Prisoners
    Rowell-Cunsolo, Tawandra L.
    Sampong, Stephen A.
    Befus, Montina
    Mukherjee, Dhritiman V.
    Larson, Elaine L.
    SUBSTANCE USE & MISUSE, 2016, 51 (02) : 261 - 267
  • [35] Treatment of Opioid-Use Disorders
    Schuckit, Marc A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04): : 357 - 368
  • [36] Opioid maintenance treatment and Cannabis use
    Schneider, Udo
    Schaefer, Ingo
    Hillemacher, Thomas
    Cimander, Konrad F.
    Wedekind, Dirk
    Weirich, Steffen
    Havemann-Reinecke, Ursula
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2019, 87 (10) : 548 - 553
  • [37] Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes
    Eastwood, Brian
    Strang, John
    Marsden, John
    DRUG AND ALCOHOL DEPENDENCE, 2018, 188 : 200 - 208
  • [38] Buprenorphine oral lyophilisate (Espranor®) in the substitution treatment of opioid dependence: a profile of its use
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2017, 33 (6) : 241 - 248
  • [39] Nutritional Implications of Opioid Use Disorder: A Guide for Drug Treatment Providers
    Chavez, Melody N.
    Rigg, Khary K.
    PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2020, 34 (06) : 699 - 707
  • [40] Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems
    Trafton, Jodie A.
    Tracy, Stephen W.
    Oliva, Elizabeth M.
    Humphreys, Keith
    JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2007, 68 (02) : 165 - 172